Can self-collection help overcome cervical screening barriers? Associate Professor Julia Brotherton says it has the potential, but must first become widely accessible and well understood in the Australian setting.
Cancer Australia releases multilingual FAQs on COVID-19 vaccines The organisation has compiled documents in 10 different languages to inform patients from diverse backgrounds about COVID-19 vaccines.
New study seeks to ‘notably’ improve ovarian cancer survival rates The world-first research will use artificial intelligence to predict risk factors of the fatal cancer over the next 15 years.
Lack of awareness key barrier to breast cancer chemoprophylaxis It can reduce the risk of breast cancer by one-third to one-half, yet new research finds 35% of GPs are unaware of chemoprophylaxis.
Media fails to cover harms of early diagnostic testing: study Researchers fear a lack of risk–benefit analysis may be contributing to overdiagnosis.
COVID vaccines and cancer patients Cancer Australia has developed a set of frequently asked questions designed to help address patient concerns.
Calls to reduce breast cancer screening age spark overdiagnosis fears New research suggests screening from age 40 has better outcomes for reducing breast cancer mortality. But is that really the case?
Study identifies four main comorbidities associated with COVID deaths Coronavirus patients with cancer, chronic kidney disease, diabetes or hypertension were found to be most at risk of death.
Provider portal to refresh cancer screening process The National Cancer Screening Register’s new eHealth portal also includes clinical software integration.
Clinical update to National Cervical Screening Program guidelines Important pathway changes for women at intermediate risk of significant cervical abnormality come into effect on 1 February.